All In MedTech

Device Trial Radar · NCT05511181

BioWave High-frequency Neurostimulation Versus TENS for the Treatment of Chronic Low Back Pain

High-frequency Sinusoidal Neurostimulation (BioWave) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Chronic Low Back Pain

Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Aug 15, 2022

Primary completion

Apr 12, 2023

Study completion Jun 30, 2023

Sponsor

Lead sponsor
BioWave CorporationNot on our public-company list
Sponsor type
Industry
Collaborators
Center For Interventional Pain and Spine; Yale University; University of Wisconsin, Madison
First posted
Aug 22, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a multicenter randomized crossover clinical trial comparing the therapeutic efficacy of BioWave therapy versus TENS for the management of chronic low back pain. This study also aims to evaluate the impact of these therapies on physical activity, patient perception of therapeutic efficacy, and activities of daily living.

Conditions

  • Chronic Pain
  • Lumbar Pain Syndrome
  • Low Back Pain

Interventions

  • BioWaveDevice

    The BioWave device is called BioWaveGO. It is a FDA 510(k) cleared high frequency sinusoidal neurostimulator

  • TENSDevice

    The TENS device is called Intensity 5000. It is a FDA 510(k) cleared TENS device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Brief Pain Inventory relative to baselineTime frame: completed pre-treatment at the initiation of the study (1st in-clinic treatment), at the 2 week follow up, at week 4, prior to the 2nd in-clinic treatment, and at the 6 week follow up
  2. Change in Visual Analogue Scale relative to baselineTime frame: completed pre-treatment and post treatment for the in-clinic visit at week 1 and week 4, as well as at the 2 week and 6 week follow up visits
  3. Change in Patient Global Impression of Change relative to baselineTime frame: completed pre-treatment and post treatment for the in-clinic visit at week 1 and week 4, as well as at the 2 week and 6 week follow up visits

1 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Yale

    New Haven, Connecticut

  • Carolinas Pain Center

    Huntersville, North Carolina

  • Center for Interventional Pain and Spine

    Lancaster, Pennsylvania

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.